Objective: To assess whether overweight children and adolescents are at an increased risk for vitamin B 12 deficiency.
I
N GENERAL, FOOD HABITS OF ADOlescents are characterized by an irregular meal pattern with skipped meals. 1 In a national survey among youth in the United States, the percentage of youth meeting national dietary recommendations was approximately 30% for the fruit, grain, meat, and dairy pyramid groups. Sixteen percent of youth did not meet any recommendations, and only 1% met all dietary recommendations. 2 Dietary intakes of several micronutrients were found to be inadequate among adolescents in several studies. 2, 3 Although it is hard to conceive of a nutritional deficiency occurring in subjects with excessive dietary and caloric intake, obese children tend to consume foods rich in carbohydrates and fat and thus may be at increased risk of micronutrient deficiency. For example, obesity has been associated with poor dietary calcium intake both in adults and in children. 4 We have reported that 38.8% of obese children had low iron levels compared with only 4.4% of normal-weight children. 5 Iron levels showed a significant negative correlation with greater standard deviation scores (SDSs) of body mass index (BMI), calculated as weight in kilograms divided by height in meters squared. Similarly, the National Health and Nutrition Examination Survey III (1988 through 1994), providing cross-sectional data on iron deficiency among children aged 2 to 16 years, showed that the prevalence of iron deficiency increased with increasing BMI and iron deficiency was particularly common among obese adolescents (9.1% compared with 3.5% in nonobese adolescents). 6 Vitamin B 12 , also known as cobalamin, is a required nutrient; its main source Author Affiliations are listed at the end of this article.
is from foods of animal origin. Vitamin B 12 deficiency is associated with hematologic, neurologic, and psychiatric manifestations. 7 Furthermore, vitamin B 12 deficiency results in hyperhomocystinemia, which is an independent risk factor for atherosclerotic disease. 8 This study aimed to assess whether obese children are at increased risk for vitamin B 12 deficiency.
METHODS
The study population comprised 392 children and adolescents aged 6 to 19 years of Sephardic and Ashkenazi Jewish origin. One hundred sixty-four were obese subjects referred to the obesity clinics of 2 endocrine centers in Israel. Two hundred twenty-eight were normal weight children referred to the endocrine clinics because of familial short stature, precocious or delayed puberty, or hirsutism and in whom no endocrine disorder was subsequently detected. Celiac disease was excluded in 103 of 128 children with short stature. We excluded children who had chronic diseases, those using vitamin supplements, those who were declared vegetarians, and those treated with metformin.
Subjects were divided into 2 groups on the basis of BMI for age and sex according to the National Institutes of Health data 9 as follows: the normal weight group had BMIs under the 95th percentile (Ͻ1.645 SDSs) for age and sex, and the obese group had BMIs at or above the 95th percentile (Ն1.645 SDSs) for age and sex.
The study protocol was approved by the human experimentation committees of Sheba and Schneider medical centers (Tel Hashomer and Petah Tikva, Israel, respectively). Written parental informed consent and child assent were obtained from obese participants. Serum B 12 concentrations were routinely taken from patients as part of initial blood test screening following an overnight fast. Serum B 12 concentration was measured using the ADVIA Centaur System, a competitive immunoassay using direct chemiluminescent technology (Bayer Diagnostics, Tarrytown, NY). Serum B 12 concentrations above 246 pg/mL were deemed normal, results between 211 and 246 pg/mL borderline were considered low, and concentrations less than 211 pg/mL indicated a B 12 deficiency as recommended by the manufacturer.
Data were analyzed with SAS software version 8.0 (SAS Institute, Cary, NC). Variables were compared using a 2 test for discrete variables and t test or Wilcoxon rank sum test for continuous variables. All tests were 2-tailed and P values below .05 were considered statistically significant. Adjusted odds ratios and 95% confidence intervals were obtained from logistic regression models with low serum B 12 concentration (Ͻ 246 pg/mL) as a dependent variable and age, sex, and obesity as predictors. Goodness-of-fit of the models was estimated by a Hosmer-Lemeshow test and c statistics.
RESULTS
Of 392 study participants, 228 were of normal weight, and 164 were obese. Age and sex distribution, BMI, and vitamin B 12 concentrations of each group are shown in Table 1 . The median serum B 12 concentration of obese children was significantly lower than that of normal weight children; 400 vs 530 pg/mL, respectively (PϽ.001). This difference was especially marked in children aged 12 years and older.
Low vitamin B 12 concentrations (Ͻ246 pg/mL) were present in 22 subjects (5.6%), 17 (10.4%) of whom were obese and 5 (2.2%) of whom were normal-weight children (PϽ.001). Vitamin B 12 concentrations below 246 pg/mL were noted in 18 (9.7%) of 186 children older than 12 years of age compared with 4 (1.9%) of 206 children aged 6 to 11 years (P = .001). The percentages of boys (4.5%) and girls (6.4%) with B 12 concentrations below 246 pg/mL were not statistically different.
Vitamin B 12 deficiency (Ͻ211 pg/mL) occurred in 12 children, 8 of whom were aged 12 to 19 years. Vitamin B 12 deficiency was present in 8 (4.9%) of the obese subjects and in 4 (1.8%) of the normal weight group (P=.08).
On multivariant analysis ( Table 2) , obesity was associated with an excess risk for low vitamin B 12 levels (odds ratio, 4.33) after adjustment for age and sex. The HosmerLemeshow goodness-of-fit test and c statistics showed that the model fitted well (P=.90, c=0.77). A similar model was conducted with BMI SDSs and age as continuous vari- 
COMMENT
Our results show that obese children and adolescents had significantly lower B 12 concentrations than normal-weight children and that 10% of obese children had low serum B 12 concentrations. Obesity was associated with a greater than 4-fold risk for low vitamin B 12 concentrations, and for each unit increase in BMI SDS, there was a 24% increase risk of low serum B 12 concentrations. To the best of our knowledge, this is the first report of low B 12 concentrations in obese children. Lower serum B 12 concentrations were detected in overweightBrazilianadolescentscomparedwiththoseofnormalweight adolescents; however, this difference did not reach statistical significance. 10 Among Thai adults, no statistically significantdifferenceinvitaminB 12 concentrationswasfound in overweight and obese subjects compared with normal control subjects. 11 Among adult Turkish patients with metabolic syndrome, serum B 12 concentrations were significantly lower than those of healthy subjects. 12 Vitamin B 12 deficiency results from decreased intake, abnormal nutrient absorption, and rare inborn errors of vitamin B 12 metabolism. [13] [14] [15] Abnormal absorption may be due to medications that decrease gastric acid secretion, pernicious anemia, infection with giardia lamblia, and any disruption of the ileal mucosa such as Crohn and celiac disease. Because obese children gain weight easily, there is no reason to suspect they have a problem with absorption. Although declared vegetarians were excluded from our study, dietary habits of obese children may be high in carbohydrate and fat and low in proteins from animal sources that contain vitamin B 12 . Indeed in a recent study, low-nutrient-density foods contributed more than 30% of daily energy intake, 16 and intake of micronutrients related inversely to intake of low-nutrientdensity foods. In the present study, although obese children were new to our clinic and had not yet been started on a weight-loss diet, it is possible that some of them had tried unbalanced diets prior to their referral to the clinic. Furthermore, it is possible that obese children have increased vitamin B 12 needs compared with nonobese children because of their increased growth and body surface area. 17 Finally, B 12 concentrations noted reflect the status in Israeli children and may not be comparable with data from other countries. For example, in our cohort, the mean B 12 concentration of normal-weight children aged 6 to 11 years was 541 pg/mL and in the 12-to 18-year-old group, 504 pg/mL, compared with 708 and 528 pg/mL in same age groups in the United States. 18 Vitamin B 12 is a cofactor in the synthesis of methionine from homocysteine; therefore, deficiency in vitamin B 12 leads to hyperhomocystinemia. Longitudinal cohort studies have established that even mild hyperhomocystinemia both predicts and precedes the development of cardiovascular morbidity and mortality. 19, 20 Hyperhomocystinemia correlated with insulin resistance in obese prepubertal children. 21 Among adults with the metabolic syndrome, levels of homocysteine were significantly higher and levels of vitamin B 12 were significantly lower compared with those of healthy subjects. 12 Homocysteinelowering treatments have resulted in improvement of cardiovascular reactivity and coagulation factors. 22 It is thus possible that vitamin B 12 deficiency may further contribute to the high risk of developing cardiovascular disease among obese children. Folate and vitamin B 12 treatment improved insulin resistance and endothelial dysfunction, along with decreasing homocysteine levels, in patients with metabolic syndrome. 23 In assessing the results of this study, a number of limitations should be considered. First, although measurement of serum vitamin B 12 concentration has been widely used as the standard screening test for deficiency, the test has poor positive and negative predictive values. 24 A "normal" concentration does not reliably exclude deficiency and low serum of vitamin B 12 concentration does not necessarily indicate deficiency. Other assays are expensive, such as those for methylmalonic acid and homocysteine, which seem to provide greater sensitivity and specificity, and concerns about the use of these assays and the interpretation of their results are emerging. 25 Second, in the absence of an Israeli population-based reference, we used the manufacturer reference for definitions of low and deficient. Vitamin B 12 concentrations in serum vary with the analytical method used and the laboratory conducting the analysis. Data from the National Health Examination Survey in the United States (1988-1994) defined B 12 deficiency as levels lower than the fifth percentile for age, which in the US population aged 4 years and older corresponded to 233 pg/mL. 18 The fifth percentile for children aged 6 to 11 years was 380 pg/mL and for those aged 12 to 19 years was 289 pg/mL. These values are higher than our cutoff levels. A detailed dietary questionnaire was not obtained from the children, so we could not correlate B 12 levels with intake.
Third, vitamin B 12 levels reflect results in Israeli children and may not be comparable with data from other countries. Lower B 12 levels have been reported in a population of young adult men in Israel compared with those of the United States. 26 Unfortunately, B 12 levels of healthy children in Israel have not been reported. Finally, although low vitamin B 12 levels were significantly more prevalent among obese children, B 12 deficiency was more prevalent only with borderline significance, maybe because of the relatively small sample size. These results are therefore preliminary observations and need further investigation.
In summary, our findings show that obese children are at high risk for low serum vitamin B 12 levels. We speculate that causes may include poor dietary content, repeated short-term restrictive diets, and increased requirements. We recommend that dietary assessment of obese children should include an estimation of vitamin B 12 and other micronutrient intakes.
